English English Compliant with international pharmacopeia monographs and ISO/HACCP frameworks, engineered for high-stability manufacturing in tropical and maritime supply routes.
Vitamin K2, specifically long-chain menaquinone-7 (MK-7), represents an essential bioactive compound commanding escalating clinical demand across global health systems. Originating via naturally derived bacterial fermentation (primarily utilizing Bacillus subtilis var. natto), MK-7 exhibits substantially superior physiological bioavailability, an extended elimination half-life (~72 hours in plasma compared to short-chain phylloquinone and MK-4), and targeted receptor activation. For laboratories, pharmaceutical import corporations, and nutraceutical plants operating in Havana and across Cuba, procuring authentic, all-trans isomeric purity is fundamental to counteracting bioavailability loss caused by tropical humidity and marine transportation transit times.
The bio-efficacy of Vitamin K2 MK7 depends directly on its stereochemical conformation. Only the all-trans isomer possesses an optimal binding affinity for γ-glutamyl carboxylase (GGCX), the hepatic and extra-hepatic enzyme accountable for the post-translational carboxylation of osteocalcin in osseous matrix and Matrix Gla Protein (MGP) within the arterial tunica media. Synthetically degraded or poorly stabilized cis-isomers are biologically inactive. Because Cuba's humid tropical climate introduces accelerated degradation risks when raw Vitamin K2 is co-formulated with reactive alkaline minerals (such as calcium carbonate or magnesium oxide), our specialized production plants utilize double micro-encapsulation techniques. By embedding MK-7 molecules in cyclodextrin or gum acacia protective spheres, our material maintains >96% active recovery even across extended maritime shipments entering the Port of Mariel or Port of Havana.
Addressing the healthcare infrastructure, domestic pharmaceutical production initiatives, and consumer nutrition patterns of the Cuban archipelago.
Cardiovascular diseases represent a primary epidemiological focus for Havana's municipal polyclinics and regional cardiology units. MK-7 activates Matrix Gla Protein (MGP), the strongest known endogenous inhibitor of arterial soft-tissue calcification. Formulating clinical supplements combining our stabilized K2 with Liposomal Vitamin D3 provides direct systemic support against arterial stiffness.
Cuba maintains one of Latin America's most elderly demographic profiles, placing significant demand on municipal osteoporosis treatment protocols. Our ultra-purified Vitamin K2 MK7 powder acts synergistically with calcium metabolism by activating osteocalcin, ensuring that dietary and supplemental calcium is bound specifically into skeletal architecture rather than settling in renal tissue.
Industrial blenders and tableting facilities located in Havana's industrial zones (such as Boyeros and Mariel Special Development Zone) require free-flowing, directly compressible (DC) powders. Our water-dispersible and oil-soluble menaquinone-7 grades accommodate cold-fill beverages, enriched dairy alternatives, softgels, and two-piece hard shell capsules.
Procuring active raw ingredients into Havana is governed by stringent regulatory evaluations overseen by CECMED (Center for State Control of Drugs, Medical Devices) and national import-export corporations such as MediCuba and MAPRREX. As Cuba emphasizes internal drug and dietary supplement synthesis to foster national health resilience, procurement agencies are transitioning away from high-cost, multi-intermediary European distributors toward direct factory-level manufacturing partners in China capable of furnishing uninterrupted, multi-year supply contracts.
Key trends include:
Backed by 15 years of industry-leading production mastery, SGS-verified infrastructure, and international trade performance exceeding US$4.28M annually.
Certified under ISO 9001:2015, ISO 22000, HACCP, HALAL, KOSHER, and FAMI-QS. Our extraction facilities in Xi'an undergo regular rigorous onsite audits by the SGS Group, confirming sanitary compliance and precision control.
Equipped with state-of-the-art dual High-Performance Liquid Chromatography (HPLC) columns, UV-Vis Spectrophotometers, analytical clean benches, and microbiological incubators ensuring all released raw materials mirror contract parameters.
Comprehensive support spanning standardized active powders, custom granulation, customized extract ratios (4:1 up to 100:1), premixes, dry syrups, and private-label packaging configured to withstand tropical distribution channels.
Clear procedural guidelines addressing import clearance, stability data, shipment terms, and testing standards.
Submit your target assay, required mesh size, and destination port. Our technical sales division will respond within 12 hours with complete dossier files, pre-shipment COAs, and competitive CIF Havana pricing.